Eicosanoyl-5-hydroxytryptamide (EHT) prevents Alzheimer’s disease-related cognitive and electrophysiological impairments in mice exposed to elevated concentrations of oligomeric beta-amyloid

Kesava Asam, Agnieszka Staniszewski, Hong Zhang, Scott L. Melideo, Adolfo Mazzeo, Michael Voronkov, Kristen L. Huber, Eduardo Pérez, Maxwell Stock, Jeffry B. Stock, Ottavio Arancio, Russell E. Nicholls

Research output: Contribution to journalArticle

4 Scopus citations

Abstract

Soluble forms of oligomeric beta-amyloid (Aβ) are thought to play a central role in Alzheimer’s disease (AD). Transgenic manipulation of methylation of the serine/threonine protein phosphatase, PP2A, was recently shown to alter the sensitivity of mice to AD-related impairments resulting from acute exposure to elevated levels of Aβ. In addition, eicosanoyl-5-hydroxytryptamide (EHT), a naturally occurring component from coffee beans that modulates PP2A methylation, was shown to confer therapeutic benefits in rodent models of AD and Parkinson’s disease. Here, we tested the hypothesis that EHT protects animals from the pathological effects of exposure to elevated levels of soluble oligomeric Aβ. We treated mice with EHT-containing food at two different doses and assessed the sensitivity of these animals to Aβ-induced behavioral and electrophysiological impairments. We found that EHT administration protected animals from Aβ-induced cognitive impairments in both a radial-arm water maze and contextual fear conditioning task. We also found that both chronic and acute EHT administration prevented Aβ-induced impairments in long-term potentiation. These data add to the accumulating evidence suggesting that interventions with pharmacological agents, such as EHT, that target PP2A activity may be therapeutically beneficial for AD and other neurological conditions.

Original languageEnglish (US)
Article numbere0189413
JournalPloS one
Volume12
Issue number12
DOIs
StatePublished - Dec 2017

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)
  • General

Fingerprint Dive into the research topics of 'Eicosanoyl-5-hydroxytryptamide (EHT) prevents Alzheimer’s disease-related cognitive and electrophysiological impairments in mice exposed to elevated concentrations of oligomeric beta-amyloid'. Together they form a unique fingerprint.

  • Cite this

    Asam, K., Staniszewski, A., Zhang, H., Melideo, S. L., Mazzeo, A., Voronkov, M., Huber, K. L., Pérez, E., Stock, M., Stock, J. B., Arancio, O., & Nicholls, R. E. (2017). Eicosanoyl-5-hydroxytryptamide (EHT) prevents Alzheimer’s disease-related cognitive and electrophysiological impairments in mice exposed to elevated concentrations of oligomeric beta-amyloid. PloS one, 12(12), [e0189413]. https://doi.org/10.1371/journal.pone.0189413